ID

37003

Beschreibung

Ibrutinib in Combination With Lenalidomide, With and Without Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02077166

Link

https://clinicaltrials.gov/show/NCT02077166

Stichworte

Versionen (1)
  1. 27.06.19 27.06.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

27. Juni 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Relapsed Diffuse Large B-Cell Lymphoma NCT02077166

Englisch

Eligibility Relapsed Diffuse Large B-Cell Lymphoma NCT02077166

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologically confirmed relapsed/ refractory dlbcl
Beschreibung

Diffuse large B-cell lymphoma recurrent | Diffuse large B-cell lymphoma refractory

Datentyp

boolean

Alias
UMLS CUI [1]
C0855111
UMLS CUI [2]
C0855112
must have previously received first line treatment regimen
Beschreibung

First line treatment Previous

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0205156
must be ineligible for high dose therapy/ stem cell transplantation
Beschreibung

Ineligibility Therapeutic procedure High dose | Ineligibility Stem cell transplant

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0444956
UMLS CUI [2,1]
C1512714
UMLS CUI [2,2]
C1504389
measurable disease sites on ct scan (>1.5 cm in longest dimension)
Beschreibung

Measurable Disease Site CT scan | Measurable Disease Longest Diameter

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1515974
UMLS CUI [1,3]
C0040405
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0552406
pt/inr <1.5 x uln and ptt (aptt) <1.5 x uln
Beschreibung

Prothrombin time assay | International Normalized Ratio | Activated Partial Thromboplastin Time measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0033707
UMLS CUI [2]
C0525032
UMLS CUI [3]
C0030605
men and women ≥18 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
ecog < 2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
adequate hepatic and renal function:
Beschreibung

Liver function | Renal function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
1. ast or alt ≤2.5 x uln
Beschreibung

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
2. creatinine clearance (cockcroft-gault or 24-hour creatinine clearance collection) >60 ml/min.
Beschreibung

Estimation of creatinine clearance by Cockcroft-Gault formula | 24 hour renal creatinine clearance

Datentyp

boolean

Alias
UMLS CUI [1]
C2711451
UMLS CUI [2]
C4032392
adequate hematologic function:
Beschreibung

Hematologic function

Datentyp

boolean

Alias
UMLS CUI [1]
C0221130
1. anc >1.50 cells/mm3
Beschreibung

Absolute neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
2. plt >75,000 cells/mm3
Beschreibung

Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
3. hgb >8.0 g/dl
Beschreibung

Hemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0518015
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
medically apparent central nervous system lymphoma or leptomeningeal disease
Beschreibung

Central nervous system lymphoma | Leptomeningeal disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0280803
UMLS CUI [2]
C0751297
history of allogeneic stem-cell (or other organ) transplantation
Beschreibung

Allogeneic Stem Cell Transplantation | Organ Transplantation

Datentyp

boolean

Alias
UMLS CUI [1]
C2242529
UMLS CUI [2]
C0029216
any chemotherapy, external beam radiation therapy, or anticancer antibodies within 2 weeks
Beschreibung

Chemotherapy | External Beam Radiation Therapy | Antineoplastic Antibody

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1517033
UMLS CUI [3]
C4329348
radio- or toxin-immunoconjugates within 10 weeks
Beschreibung

Radioimmunoconjugates | Toxin Immunoconjugates

Datentyp

boolean

Alias
UMLS CUI [1]
C0243019
UMLS CUI [2,1]
C0040549
UMLS CUI [2,2]
C0243020
concurrent enrollment in another therapeutic investigational study or have previously taken ibrutinib and/or lenalidomide.
Beschreibung

Study Subject Participation Status | Therapies, Investigational | Ibrutinib | lenalidomide

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0949266
UMLS CUI [3]
C3501358
UMLS CUI [4]
C1144149
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Relapsed Diffuse Large B-Cell Lymphoma NCT02077166

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diffuse large B-cell lymphoma recurrent | Diffuse large B-cell lymphoma refractory
Item
pathologically confirmed relapsed/ refractory dlbcl
boolean
C0855111 (UMLS CUI [1])
C0855112 (UMLS CUI [2])
First line treatment Previous
Item
must have previously received first line treatment regimen
boolean
C1708063 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Ineligibility Therapeutic procedure High dose | Ineligibility Stem cell transplant
Item
must be ineligible for high dose therapy/ stem cell transplantation
boolean
C1512714 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,3])
C1512714 (UMLS CUI [2,1])
C1504389 (UMLS CUI [2,2])
Measurable Disease Site CT scan | Measurable Disease Longest Diameter
Item
measurable disease sites on ct scan (>1.5 cm in longest dimension)
boolean
C1513041 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0552406 (UMLS CUI [2,2])
Prothrombin time assay | International Normalized Ratio | Activated Partial Thromboplastin Time measurement
Item
pt/inr <1.5 x uln and ptt (aptt) <1.5 x uln
boolean
C0033707 (UMLS CUI [1])
C0525032 (UMLS CUI [2])
C0030605 (UMLS CUI [3])
Age
Item
men and women ≥18 years of age
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog < 2
boolean
C1520224 (UMLS CUI [1])
Liver function | Renal function
Item
adequate hepatic and renal function:
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
1. ast or alt ≤2.5 x uln
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Estimation of creatinine clearance by Cockcroft-Gault formula | 24 hour renal creatinine clearance
Item
2. creatinine clearance (cockcroft-gault or 24-hour creatinine clearance collection) >60 ml/min.
boolean
C2711451 (UMLS CUI [1])
C4032392 (UMLS CUI [2])
Hematologic function
Item
adequate hematologic function:
boolean
C0221130 (UMLS CUI [1])
Absolute neutrophil count
Item
1. anc >1.50 cells/mm3
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
2. plt >75,000 cells/mm3
boolean
C0032181 (UMLS CUI [1])
Hemoglobin measurement
Item
3. hgb >8.0 g/dl
boolean
C0518015 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Central nervous system lymphoma | Leptomeningeal disease
Item
medically apparent central nervous system lymphoma or leptomeningeal disease
boolean
C0280803 (UMLS CUI [1])
C0751297 (UMLS CUI [2])
Allogeneic Stem Cell Transplantation | Organ Transplantation
Item
history of allogeneic stem-cell (or other organ) transplantation
boolean
C2242529 (UMLS CUI [1])
C0029216 (UMLS CUI [2])
Chemotherapy | External Beam Radiation Therapy | Antineoplastic Antibody
Item
any chemotherapy, external beam radiation therapy, or anticancer antibodies within 2 weeks
boolean
C0392920 (UMLS CUI [1])
C1517033 (UMLS CUI [2])
C4329348 (UMLS CUI [3])
Radioimmunoconjugates | Toxin Immunoconjugates
Item
radio- or toxin-immunoconjugates within 10 weeks
boolean
C0243019 (UMLS CUI [1])
C0040549 (UMLS CUI [2,1])
C0243020 (UMLS CUI [2,2])
Study Subject Participation Status | Therapies, Investigational | Ibrutinib | lenalidomide
Item
concurrent enrollment in another therapeutic investigational study or have previously taken ibrutinib and/or lenalidomide.
boolean
C2348568 (UMLS CUI [1])
C0949266 (UMLS CUI [2])
C3501358 (UMLS CUI [3])
C1144149 (UMLS CUI [4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video